These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 10225708

  • 1. Leukocytapheresis therapy for severe ulcerative colitis.
    Sasaki M, Tsujikawa T, Fujiyama Y, Bamba T.
    Ther Apher; 1998 May; 2(2):101-4. PubMed ID: 10225708
    [Abstract] [Full Text] [Related]

  • 2. Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis.
    Sawada K, Ohnishi K, Kosaka T, Chikano S, Yokota Y, Egashira A, Izawa H, Yamamura M, Amano K, Satomi M, Shimoyama T.
    Ther Apher; 1997 Aug; 1(3):207-11. PubMed ID: 10225739
    [Abstract] [Full Text] [Related]

  • 3. A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis.
    Kobayashi T, Matsuoka K, Yokoyama Y, Nakamura T, Ino T, Numata T, Shibata H, Aoki H, Matsuno Y, Hibi T.
    J Gastroenterol; 2018 Mar; 53(3):387-396. PubMed ID: 28597225
    [Abstract] [Full Text] [Related]

  • 4. Univariate analysis to examine predictors of response to leukocytapheresis in ulcerative colitis patients.
    Nagayama K, Takedatsu H, Mitsuyama K, Yamasaki H, Kuwaki K, Yoshioka S, Kobayashi T, Yamauchi R, Kakuma T, Sata M.
    Ther Apher Dial; 2014 Jun; 18(3):244-51. PubMed ID: 24965290
    [Abstract] [Full Text] [Related]

  • 5. Influence of leukocytapheresis therapy for ulcerative colitis on anemia and hemodynamics.
    Miyamoto H, Okahisa T, Iwaki H, Murata M, Ito S, Nitta Y, Akutagawa M, Kinouchi Y, Ohnishi Y, Oto J, Nishimura M.
    Ther Apher Dial; 2007 Feb; 11(1):16-21. PubMed ID: 17309570
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y, Iwakiri R, Amemori S, Yamaguchi K, Fujise T, Otani H, Shimoda R, Tsunada S, Sakata H, Ikeda Y, Ando T, Nakafusa Y, Fujimoto K.
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [Abstract] [Full Text] [Related]

  • 7. Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.
    Sawada K, Egashira A, Ohnishi K, Fukunaga K, Kusaka T, Shimoyama T.
    Dig Dis Sci; 2005 Apr; 50(4):767-73. PubMed ID: 15844716
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extracorporeal elimination of TNF-alpha-producing CD14(dull)CD16(+) monocytes in leukocytapheresis therapy for ulcerative colitis.
    Kanai T, Makita S, Kawamura T, Nemoto Y, Kubota D, Nagayama K, Totsuka T, Watanabe M.
    Inflamm Bowel Dis; 2007 Mar; 13(3):284-90. PubMed ID: 17206704
    [Abstract] [Full Text] [Related]

  • 11. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis.
    Shimada M, Iwase H, Tsuzuki T, Hirashima N, Kobayashi K, Hibino Y, Watanabe H, Ryuge N, Ando T, Goto H, Yagi Y, Tsujikawa T, Andoh A.
    Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719
    [Abstract] [Full Text] [Related]

  • 12. Predictive factors of response to leukocytapheresis therapy for ulcerative colitis.
    Yajima T, Takaishi H, Kanai T, Iwao Y, Watanabe M, Ishii H, Hibi T.
    Ther Apher; 1998 May; 2(2):115-9. PubMed ID: 10225711
    [Abstract] [Full Text] [Related]

  • 13. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy.
    Nishioka C, Aoyama N, Maekawa S, Shirasaka D, Nakahara T, Tamura T, Fukagawa M, Umezu M, Abe T, Kasuga M.
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075
    [Abstract] [Full Text] [Related]

  • 14. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.
    Sawada K, Kusugami K, Suzuki Y, Bamba T, Munakata A, Hibi T, Shimoyama T.
    Am J Gastroenterol; 2005 Jun; 100(6):1362-9. PubMed ID: 15929771
    [Abstract] [Full Text] [Related]

  • 15. [Leukocytapheresis for ulcerative colitis].
    Fukunaga K, Sawada K, Chikano S, Ohnishi K, Egashira A, Tanaka J, Nagase K, Satomi M, Shimoyama T.
    Nihon Rinsho; 1999 Nov; 57(11):2496-502. PubMed ID: 10572419
    [Abstract] [Full Text] [Related]

  • 16. Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients.
    Fukunaga K, Fukuda Y, Yokoyama Y, Ohnishi K, Kusaka T, Kosaka T, Hida N, Ohda Y, Miwa H, Matsumoto T.
    J Gastroenterol; 2006 Jun; 41(6):524-32. PubMed ID: 16868799
    [Abstract] [Full Text] [Related]

  • 17. Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease.
    Sawada K, Ohnishi K, Kosaka T, Fukui S, Yamamura M, Amano K, Satomi M, Shimoyama T.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():124-7. PubMed ID: 8563873
    [Abstract] [Full Text] [Related]

  • 18. [Mechanism of leukocytapheresis effect in the treatment of ulcerative colitis].
    Sawada K, Ohnishi K, Fukunaga K, Chikano S, Egashira A, Satomi M, Shimoyama T.
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Dec; 22(6):469-74. PubMed ID: 10726487
    [Abstract] [Full Text] [Related]

  • 19. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis.
    Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Kikuyama M, Tanaka T, Kondo K, Tanaka K, Takai K.
    World J Gastroenterol; 2005 May 28; 11(20):3085-90. PubMed ID: 15918195
    [Abstract] [Full Text] [Related]

  • 20. Extracorporeal leukocyte removal therapy for patients with ulcerative colitis.
    Kumagai M, Yamato Y, Maeda K, Nakashima E, Ushijima K, Kimura A.
    Pediatr Int; 2007 Aug 28; 49(4):431-6. PubMed ID: 17587263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.